Eckert & Ziegler to open U.S. isotope facility

By staff writers

February 6, 2020 -- Isotope technology firm Eckert & Ziegler has unveiled plans to open a radiopharmaceutical production site in Massachusetts.

The company has signed a long-term rental contract for a suitable building in Wilmington to produce the radioisotope yttrium-90 (Y-90), which is used in oncological applications for the treatment of liver cancer.

The decision to open a U.S. facility was prompted by the announcement last year that a Y-90 manufacturer was closing its U.S. operations.

Eckert & Ziegler last year had agreed to bring its Y-90 production technology to a partner in Chengdu, China, which would in return give Eckert & Ziegler long-term, exclusive global marketing and sales rights. Once the Boston plant is operational, the company expects to offer local supply of Y-90 to pharmaceutical companies or hospitals in all regions of the world.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking